[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339889-105":59,"doc-detail-339889-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","identification-of-genes-hub-associated-with-triple-negative-breast-cancer-and-cannabidiol-analogs-potential-inhibitory-agents-an-in-silico-study","Identification of Genes Hub Associated with Triple-Negative Breast Cancer and Cannabidiol Analogs Potential Inhibitory Agents - An In-silico Study","","Triple-negative breast cancer presents major therapeutic challenges due to aggressive behavior and the absence of common hormone receptors and HER2. This in-silico study performs bioinformatic identification of hub genes linked to TNBC using the GSE178748 expression dataset and MDA-MB-231 cell lines, combining differential expression, protein-protein interaction networks, and validation. Cannabidiol analogs are then evaluated as inhibitory candidates via molecular docking and dynamics, with stability and binding confirmed by RMSD, RMSF, SASA, Gyration Radius, and MMGBSA.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-genes-hub-associated-with-triple-negative-breast-cancer-and-cannabidiol-analogs-potential-inhibitory-agents-an-in-silico-study/339889/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-genes-hub-associated-with-triple-negative-breast-cancer-and-cannabidiol-analogs-potential-inhibitory-agents-an-in-silico-study/339889.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main objective?","Question",{"text":113,"@type":114},"To identify hub genes associated with triple-negative breast cancer using bioinformatic analysis and to evaluate cannabidiol analogs as potential inhibitory agents against these hub genes through docking and molecular dynamics.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were hub genes identified?",{"text":118,"@type":114},"Gene expression profiles from the GSE178748 dataset were analyzed for MDA-MB-231 breast cancer cell lines, and differentially expressed genes were determined through protein-protein interaction networks and subsequent validation.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genes and ligands showed the most notable results?",{"text":122,"@type":114},"RPL7A, NHP2L1, and PSMD11 were highlighted as significant hub genes. Ligand 44409296 showed the best affinity with RPL7A, while ligand 166505341 showed the highest affinity with NHP2L1 and PSMD11.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339889,1790171752,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \nEditorial Process: Submission:12/18/2023 Acceptance:05/07/2024  \nIdentification of Genes Hub Associated with Triple-Negative Breast Cancer and Cannabidiol Analogs Potential Inhibitory Agents: An In-silico Study  \nNeyder Contreras-Puentes1, Antistio Alviz-Amador2 *, Janer Andres ZabaletaGuzman2, Rafael Pineda-Aleman2, Arnulfo Taron-Dunoyer3  \nAbstract  \nObjective: Triple-negative breast cancer presents a significant challenge in oncology due to its complex treatment and aggressive nature. This subtype lacks common cancer cell receptors like estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. This study aimed to identify, through bioinformatic analysis, the key genes associated with triple-negative breast cancer. In addition, CBD analogs with potential inhibitory effects on these genes were evaluated through docking and molecular dynamics. Methods: Gene expression profiles from the GSE178748 dataset were analyzed, focusing on MDA-MB-231 breast cancer cell lines. Differentially expressed genes were determined through protein-protein interaction networks and subsequently validated. Additionally, the inhibitory effects of cannabidiol analogs on these hub genes were assessed using molecular docking and dynamics. Results: Analysis of the hub highlighted RPL7A, NHP2L1, and PSMD11 as significant players in TNBC regulation. Ligand 44409296 showed the best affinity energy with RPL7A, while 166505341 exhibited the highest affinity with NHP2L1 and PSMD11, surpassing CBD. Analyses of RMSD, RMSF, SASA, and Gyration Radius indicated structural stability and interactions of the proteins with ligands over time. MMGBSA calculations showed favorable binding energies for the ligands with the target proteins. Conclusion: In conclusion, this study identified key genes, namely RPL7A, NHP2L1, and PSMD11, associated with triple-negative breast cancer and demonstrated promising interactions with cannabidiol analogs, particularly 44409296 and 166505341. These findings suggest potential therapeutic targets and highlight the relevance of further clinical investigations. Additionally, the ligands exhibited favorable ADME properties and low toxicity, underscoring their potential in future drug development for TNBC treatment.  \nKeywords: Triple-negative breast cancer-Molecular Docking-Bioinformatic analysis-Cannabidiol  \nAsian Pac J Cancer Prev, 25 (5), 1649-1661  \nIntroduction  \nTriple-negative breast cancer has emerged as a significant challenge in the field of oncology due to its complex treatment and highly aggressive nature. This cancer subtype is characterized by the absence of typical receptors in cancer cells, such as estrogen and progesterone receptors, and by the overexpression of human epidermal growth factor receptor 2 (HER2) receptors [1,2] . It is estimated that triple-negative breast cancer accounts for approximately 10 to 15% of all diagnosed cases of breast cancer [1] . Furthermore, there is a higher likelihood of this type of cancer developing in women under the age of 40, particularly in those of African descent or those with a mutation in the BRCA1 gene [2] .  \nOne of the most studied genetic biomarkers in TNBC  \nis the mutational status of the BRCA1 and BRCA2 genes, which encode proteins involved in DNA repair through homologous recombination. Mutations in these genes are associated with a higher risk of developing TNBC [3] . In addition to genes involved in DNA repair, other genetic biomarkers could be relevant in TNBC, such as those related to cellular signaling pathways, metabolism, angiogenesis, or immune response [4]. Thus, the search for genetic biomarkers and innovative therapies has become a crucial necessity to comprehend the underlying biology of this disease and develop diagnostic strategies for more precise treatments. Genetic and protein biomarkers may play a significant role in the diagnosis, prognosis, treatment selection for TNBC, risk of recurrence, and patient survival [5] .","cbCaiibCBeLLOWPr","https://ap.wps.com/l/cbCaiibCBeLLOWPr","pdf",1721301,13,"English","# Abstract\n# Introduction\n## Key genetic biomarkers in TNBC\n## Bioinformatic development for biomarker discovery\n## Cannabinoids and CBD in breast cancer","[{\"question\":\"What is the study’s main objective?\",\"answer\":\"To identify hub genes associated with triple-negative breast cancer using bioinformatic analysis and to evaluate cannabidiol analogs as potential inhibitory agents against these hub genes through docking and molecular dynamics.\"},{\"question\":\"How were hub genes identified?\",\"answer\":\"Gene expression profiles from the GSE178748 dataset were analyzed for MDA-MB-231 breast cancer cell lines, and differentially expressed genes were determined through protein-protein interaction networks and subsequent validation.\"},{\"question\":\"Which genes and ligands showed the most notable results?\",\"answer\":\"RPL7A, NHP2L1, and PSMD11 were highlighted as significant hub genes. Ligand 44409296 showed the best affinity with RPL7A, while ligand 166505341 showed the highest affinity with NHP2L1 and PSMD11.\"}]","Identification of Genes Hub Associated with Triple-Negative Breast Cancer and Cannabidiol Analogs Potential Inhibitory Agents - An In-silico Study | PDF",1790032952,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/158637de32d7c608d899d30d7b54639a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f13a3b5a4783babadedcb73ab9faa36.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9777916b60c1d6e0ee5bcbfc6cb427e2.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c001181aea2d99fc5a18cfddf0e6eb6.webp",980,1385]